Advances in the Role of Helper T Cells in Autoimmune Diseases
Autoimmune diseases are a group of disorders characterized by the immune system mistakenly attacking the body’s own tissues, leading to tissue damage and organ dysfunction. These diseases are mediated by immune effector cells such as cytotoxic T lymphocytes (CTLs), natural killer cells (NKs), macrophages, and immune effector molecules like complements, antibodies, and cytokines. Over 100 types of autoimmune diseases affect people worldwide, and their pathogenesis involves a complex interplay of genetic predisposition, environmental triggers, and immune dysregulation. Among the key players in autoimmune diseases are helper T cells, which play a critical role in the immune response by activating other immune cells, producing cytokines, and regulating immune tolerance. This review focuses on the role of helper T cells in autoimmune diseases, particularly their involvement in B cell-mediated autoantibody production and the activation of abnormal lymphocytes.
Helper T Cells and Autoimmune Diseases
Helper T cells (Th cells) are a subset of CD4+ T cells that play a central role in orchestrating the immune response. They are classified into several subsets based on their cytokine profiles and functions, including Th1, Th2, Th17, T follicular helper (Tfh) cells, and regulatory T cells (Tregs). Each subset has distinct roles in immune regulation, and their dysregulation is implicated in the pathogenesis of various autoimmune diseases.
Th1 and Th2 Cells in Autoimmunity
Th1 cells are primarily involved in cell-mediated immunity and produce cytokines such as interferon-gamma (IFN-γ) and interleukin-2 (IL-2). Th2 cells, on the other hand, are associated with humoral immunity and produce cytokines like IL-4, IL-5, and IL-13. The balance between Th1 and Th2 cells is crucial for maintaining immune homeostasis. In autoimmune diseases, an imbalance in Th1/Th2 responses can lead to the development of autoimmunity. For example, in idiopathic thrombocytopenic purpura (ITP), an increase in Th1 subsets and a decrease in Th2 subsets contribute to the development of autoreactive B cells. Similarly, in systemic sclerosis (SSc), Th2 cells and their related cytokines play a key role in promoting fibrosis and inflammation.
Th17 Cells in Autoimmunity
Th17 cells are a subset of helper T cells that produce IL-17, a pro-inflammatory cytokine involved in the pathogenesis of many autoimmune diseases. Th17 cells are implicated in diseases such as autoimmune hemolytic anemia (AIHA), multiple sclerosis (MS), and rheumatoid arthritis (RA). In AIHA, Th17 cells and IL-17 secretion are closely related to disease activity. In MS, Th17 cells are the major promoters of pathology, and their differentiation and activation are key targets for therapeutic intervention. In RA, Th17 cells contribute to inflammation and bone destruction by producing IL-17, which induces fibroblast activation and osteoclastogenesis.
T Follicular Helper (Tfh) Cells in Autoimmunity
Tfh cells are specialized helper T cells that reside in germinal centers and provide essential help to B cells for antibody production. Tfh cells are involved in the pathogenesis of autoimmune diseases such as systemic lupus erythematosus (SLE) and myasthenia gravis (MG). In SLE, Tfh cells promote the differentiation of self-reactive B cells into plasma cells, leading to the production of autoantibodies. In MG, Tfh cells are increased in the thymus and peripheral blood, suggesting their role in the selection and survival of B cells that produce pathogenic antibodies against the acetylcholine receptor (AChR).
Regulatory T Cells (Tregs) in Autoimmunity
Tregs are a subset of helper T cells that maintain immune tolerance by suppressing the activation and proliferation of autoreactive T cells. In autoimmune diseases, Tregs are often reduced in number or function, leading to a loss of immune tolerance. For example, in ITP, the levels of Tregs are significantly decreased, while the levels of Th17 cells are increased, resulting in an imbalance in the Treg/Th17 ratio. Similarly, in SLE, Tregs are decreased in the peripheral blood, and their dysfunction is associated with disease activity. In RA, the imbalance between Th17 and Treg cells contributes to chronic inflammation and joint destruction.
B Cell-Mediated Autoimmune Diseases
B cells play a critical role in autoimmune diseases by producing autoantibodies that target self-antigens. Helper T cells are essential for the activation and differentiation of B cells into plasma cells that produce these autoantibodies. The following sections discuss the role of helper T cells in specific B cell-mediated autoimmune diseases.
Autoimmune Hemolytic Anemia (AIHA)
AIHA is characterized by the production of autoantibodies against red blood cells (RBCs), leading to their premature destruction. Helper T cells, particularly Th17 cells, are key players in the pathogenesis of AIHA. Studies have shown that Th17 cells and IL-17 secretion are increased in AIHA patients, and adoptive transfer of Th17 cells enhances the production of anti-erythrocyte antibodies in animal models. Additionally, Tfh cells are increased in AIHA mouse models, suggesting their role in B cell differentiation and antibody production. Strategies aimed at inhibiting Tfh cell development or function may be effective in treating AIHA.
Idiopathic Thrombocytopenic Purpura (ITP)
ITP is characterized by increased platelet destruction due to autoantibodies against platelet glycoproteins. Helper T cells, particularly Th1 and Th17 cells, are involved in the pathogenesis of ITP. Th1 cells promote the development of autoreactive B cells, while Th17 cells contribute to inflammation and platelet destruction. Tregs are significantly reduced in ITP patients, and their levels improve with treatment, suggesting their role in maintaining immune tolerance. Tfh cells are also increased in ITP patients, particularly in those with anti-platelet antibodies, indicating their involvement in B cell activation and antibody production.
Systemic Lupus Erythematosus (SLE)
SLE is a chronic autoimmune disease characterized by the production of autoantibodies against nuclear antigens, leading to immune complex deposition and tissue damage. Helper T cells, particularly Tfh cells, play a critical role in the pathogenesis of SLE. Tfh cells promote the differentiation of self-reactive B cells into plasma cells, leading to the production of autoantibodies. Th17 cells are also increased in SLE patients, and their levels are associated with disease activity. Tregs are decreased in SLE patients, and their dysfunction contributes to the loss of immune tolerance.
Myasthenia Gravis (MG)
MG is a chronic autoimmune disorder of neuromuscular transmission characterized by muscle weakness due to autoantibodies against the acetylcholine receptor (AChR). Helper T cells, particularly Th1 and Th17 cells, are involved in the pathogenesis of MG. Th1 and Th17 cells produce cytokines that promote the production of pathogenic AChR antibodies. Tfh cells are increased in the thymus and peripheral blood of MG patients, suggesting their role in B cell activation and antibody production. Tregs are decreased in MG patients, and their dysfunction contributes to the chronic inflammatory state in the thymus.
T Cell-Mediated Autoimmune Diseases
In addition to B cell-mediated autoimmune diseases, helper T cells also play a critical role in T cell-mediated autoimmune diseases. The following sections discuss the role of helper T cells in specific T cell-mediated autoimmune diseases.
Multiple Sclerosis (MS)
MS is an autoimmune disease that targets the central nervous system, leading to demyelination and neurological dysfunction. Th17 cells are the major promoters of pathology in MS, and their differentiation and activation are key targets for therapeutic intervention. Th1 cells are also involved in the pathogenesis of MS, particularly in the early stages of the disease. Th9 and Th22 cells are implicated in the regulation of inflammation in MS, and their levels are associated with disease activity.
Rheumatoid Arthritis (RA)
RA is a chronic inflammatory autoimmune disease characterized by joint inflammation and destruction. Th17 cells play a critical role in the pathogenesis of RA by producing IL-17, which induces inflammation and bone destruction. Tregs are decreased in RA patients, and their dysfunction contributes to the imbalance between pro-inflammatory and anti-inflammatory responses. Th22 cells are increased in RA patients, and their levels are associated with disease activity, suggesting their role in promoting inflammation and bone destruction.
Inflammatory Bowel Disease (IBD)
IBD is a group of chronic inflammatory diseases of the gastrointestinal tract, including Crohn’s disease (CD) and ulcerative colitis (UC). Helper T cells, particularly Th1, Th17, and Th9 cells, are involved in the pathogenesis of IBD. Th1 cells promote inflammation in CD, while Th17 cells contribute to inflammation in both CD and UC. Th9 cells are increased in UC patients, and their levels are associated with disease progression. Tregs are decreased in IBD patients, and their dysfunction contributes to the loss of immune tolerance in the intestinal mucosa.
Conclusion
Helper T cells play a critical role in the pathogenesis of autoimmune diseases by promoting the activation and differentiation of B cells, producing pro-inflammatory cytokines, and regulating immune tolerance. The dysregulation of helper T cell subsets, including Th1, Th2, Th17, Tfh, and Treg cells, is implicated in the development of various autoimmune diseases. Understanding the role of helper T cells in autoimmune diseases provides valuable insights into the mechanisms of autoimmunity and offers potential targets for therapeutic intervention. Future research should focus on developing strategies to restore the balance of helper T cell subsets and enhance immune tolerance in autoimmune diseases.
doi.org/10.1097/CM9.0000000000000748
Was this helpful?
0 / 0